Why Viridian Therapeutics, Inc. (VRDN) stock rose 15.5% on Wednesday, November 4, 2026

Viridian Therapeutics, Inc. (VRDN) closed at $29.06, up 15.53% on Wednesday, November 4, 2026, on volume of 11,043,193 shares (5.9× its 3-month average); market value about $3.30B.

What happened: primary sources

Events Nexqual found for VRDN on Wednesday, November 4, 2026 or the trading day before (November 3, 2026):

• Nov 4, 2026: Reported Q3 2026 results: EPS −$0.81 vs consensus −$1.02 (beat), revenue $25.8M vs consensus $4.7M (beat). source
• Nov 4, 2026: Needham: Target raised, Buy, price target $34 → $38

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on VRDN

VRDN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: VRDN results, November 4, 2026. Other big moves that day: November 4, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:45 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:45 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt